Literature DB >> 11378271

Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor: implications for multi-step oncogenesis.

V Prassolov1, J Meyer, G Brandenburg, J Hannemann, J Bergemann, W Ostertag, C Stocking.   

Abstract

OBJECTIVE: A truncated common beta chain (Deltabeta(C)) of the interleukin-3 (IL-3) receptor complex was previously identified as a key factor in inducing autonomous growth of IL-3-independent mutants. Expression of Deltabeta(C) in IL-3-dependent hematopoietic cells does not result in immediate factor-independent growth, but increases the frequency of obtaining autonomous mutants by three to four orders of magnitude. This study was designed to delineate the mechanisms by which Deltabeta(C) increases the frequency to autonomous growth. DESIGN AND METHODS: Retroviral vectors were used to express Deltabeta(C) into IL-3-dependent myeloid cells, which were then tested for factor-independent growth. To determine if secondary genetic events were required for conversion to autonomous growth, elements of the Cre-loxP recombinant system were used to excise Deltabeta(C) in factor-independent clones.
RESULTS: Excision of Deltabeta(C) in factor-independent clones revealed two types of phenotypes: reversion to factor-dependent growth (1/8) or continued IL-3-dependent growth (7/8). Analysis of cells that remained factor independent revealed constitutive activation of STAT5, not observed in factor-dependent revertants. Analysis of revertant cells demonstrated the presence of interacting secondary mutations that synergize with Deltabeta(C)-induced proliferation. A cysteine residue within the truncated extracellular domain of Deltabeta(C) was also found to be required for its oncogenic potential, supporting a model of dimerization for receptor activation.
CONCLUSIONS: The high incidence of obtaining factor-independent mutants from cells expressing Deltabeta(C) results from the selection of mutations that either complement Deltabeta(C) expression to promote proliferation or that singly or in synergy with other secondary mutations negate the requirement of Deltabeta(C) expression for proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378271     DOI: 10.1016/s0301-472x(01)00648-8

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  Unmodified Cre recombinase crosses the membrane.

Authors:  Elke Will; Hannes Klump; Nicole Heffner; Maike Schwieger; Bernhard Schiedlmeier; Wolfram Ostertag; Christopher Baum; Carol Stocking
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.

Authors:  M M Prokofjeva; P V Spirin; D V Yanvarev; A V Ivanov; M S Novikov; O A Stepanov; M B Gottikh; S N Kochetkov; B Fehse; C Stocking; V S Prassolov
Journal:  Acta Naturae       Date:  2011-10       Impact factor: 1.845

3.  Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations.

Authors:  Kevin Watanabe-Smith; Jamila Godil; Anupriya Agarwal; Cristina Tognon; Brian Druker
Journal:  Oncotarget       Date:  2017-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.